Here's Why Axogen, Inc. Fell As Much As 18.6% Today

Shares of AxoGen (NASDAQ: AXGN) fell nearly 19% today after the company reported second-quarter 2018 earnings. The healthcare company, which develops and markets surgical solutions for peripheral nerves, actually reported a solid quarter of sales growth compared to the year-ago period. Revenue increased 36% compared to the second quarter of 2017.However, the top-line growth was overshadowed by a huge increase in expenses and overhead, which led to a larger net loss in the second quarter of 2018 compared to the year-ago period.

Topics:  axogen nasdaq   axgn    axogen   fell   today   compared   loss   net   reported   quarter   company   year-ago   period   growth   million   

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News